| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Moreadith Randall is a Chief Scientific Officer at SER. Recent filings cover 0 purchases and 41 sales.
Our model assigns Moreadith Randall a strong insider score of 89/100, based on 38 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +62.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $5.89 | $38,285.00 | -100% | -11.3% | -63.8% | |
| Jul 21, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $5.34 | $34,710.00 | -100% | -9.5% | -60.9% | |
| Jul 14, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $5.01 | $32,565.00 | -100% | -2.7% | -59.4% | |
| Jul 7, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $5.67 | $36,855.00 | -100% | -6.5% | -60.9% | |
| Jun 30, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $5.78 | $37,570.00 | -100% | -20.6% | -68.5% |